Ticlopidine Hydrochloride

CHEMBL1717 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
300.2 g/mol
LogP
Phase
4

A hydrochloride salt form of ticlopidine with the same therapeutic properties. This antiplatelet medication reduces the risk of stroke in patients who have had a previous stroke or TIA (mini-stroke) and cannot take aspirin.

الوزن الجزيئي

300,2000 g/mol

TPSA

31,50 Ų

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.Clc1ccccc1CN1CCc2sccc2C1

InChI

InChI=1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H

Molecular Formula

C14H15Cl2NS

HBD / HBA

1 / 2

الروابط القابلة للدوران

2

الذرات الثقيلة

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A hydrochloride salt form of ticlopidine with the same therapeutic properties. This antiplatelet medication reduces the risk of stroke in patients who have had a previous stroke or TIA (mini-stroke) and cannot take aspirin.

Yes, Ticlopidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1717. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65335. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.